Misplaced Pages

Niceritrol

Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	C10AD01 (WHO)
Identifiers
IUPAC name 3--2,2-bis({methyl})propyl pyridine-3-carboxylate
CAS Number	5868-05-3
PubChem CID	4476
ChemSpider	4321
UNII	F54EHJ34MV
KEGG	D01754
CompTox Dashboard (EPA)	DTXSID1023364
ECHA InfoCard	100.025.017
Chemical and physical data
Formula	C29H24N4O8
Molar mass	556.531 g·mol
3D model (JSmol)	Interactive image
SMILES C1=CC(=CN=C1)C(=O)OCC(COC(=O)C2=CN=CC=C2)(COC(=O)C3=CN=CC=C3)COC(=O)C4=CN=CC=C4
InChI InChI=1S/C29H24N4O8/c34-25(21-5-1-9-30-13-21)38-17-29(18-39-26(35)22-6-2-10-31-14-22,19-40-27(36)23-7-3-11-32-15-23)20-41-28(37)24-8-4-12-33-16-24/h1-16H,17-20H2 Key:KUEUWHJGRZKESU-UHFFFAOYSA-N
(what is this?)  (verify)

Niceritrol is a niacin derivative used as a hypolipidemic agent. It is an ester of pentaerythritol and nicotinic acid, has general properties similar to those of nicotinic acid (Nicotinamide), to which it is slowly hydrolysed. Niceritrol has been used as a lipid regulating drug in hyperlipidaemias and as a vasodilator in the treatment of peripheral vascular disease.

References

1. Owada A, Suda S, Hata T (April 2003). "Antiproteinuric effect of niceritrol, a nicotinic acid derivative, in chronic renal disease with hyperlipidemia: a randomized trial". The American Journal of Medicine. 114 (5): 347–53. doi:10.1016/s0002-9343(02)01567-x. PMID 12714122.
2. Truven Health Analytics Inc. (May 8, 2008). "Niceritrol". Micromedexsolutions.com. Retrieved December 14, 2014.

This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Nicotinate esters
• Cardiovascular system drug stubs